# Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)

> **NCT00158522** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 31 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** pegylated interferon alpha2a

## Key facts

- **NCT ID:** NCT00158522
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2008-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158522, "Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00158522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*